@article{fc00d0e981e8414a899df4c13e81f057,
title = "Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers",
abstract = "To determine whether adjuvant tamoxifen treatment for breast cancer (BC) is associated with reduced contralateral breast cancer (CBC) risk for BRCA1 and/or BRCA2 mutation carriers.",
keywords = "Adult, Aged, Breast Neoplasms, Estrogen Antagonists, Female, Genes, BRCA1, Genes, BRCA2, Heterozygote, Humans, Middle Aged, Mutation, Proportional Hazards Models, Risk Factors, Tamoxifen",
author = "Kelly-Anne Phillips and Milne, \{Roger L\} and Rookus, \{Matti A\} and Daly, \{Mary B\} and Antoniou, \{Antonis C\} and Susan Peock and Debra Frost and Easton, \{Douglas F\} and Steve Ellis and Friedlander, \{Michael L\} and Buys, \{Saundra S\} and Nadine Andrieu and Catherine Nogu{\`e}s and Dominique Stoppa-Lyonnet and Val{\'e}rie Bonadona and Pascal Pujol and McLachlan, \{Sue Anne\} and John, \{Esther M\} and Hooning, \{Maartje J\} and Caroline Seynaeve and Tollenaar, \{Rob A E M\} and Goldgar, \{David E\} and Terry, \{Mary Beth\} and Trinidad Caldes and Weideman, \{Prue C\} and Andrulis, \{Irene L\} and Singer, \{Christian F\} and Kate Birch and Jacques Simard and Southey, \{Melissa C\} and Olsson, \{H{\aa}kan L\} and Anna Jakubowska and Edith Olah and Anne-Marie Gerdes and Lenka Foretova and Hopper, \{John L\}",
year = "2013",
month = sep,
day = "1",
doi = "10.1200/JCO.2012.47.8313",
language = "English",
volume = "31",
pages = "3091--9",
journal = "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",
issn = "0732-183X",
publisher = "Spandidos Publications",
number = "25",
}